The Contract Development and Manufacturing Organization (CDMO) sector is undergoing a remarkable transformation as a result of significant geopolitical shifts in 2024. These transformations are exerting considerable influence on supply chain dynamics, regulatory landscapes, and market strategies,
Continuous Manufacturing (CM) is revolutionizing the pharmaceutical industry, particularly in the production of biologics. This article explores the advancements and advantages of CM, focusing on the concept of Fully Connected Continuous Manufacturing (FCCM) and its impact on biologics production,
The pharmaceutical industry's research and development (R&D) landscape is undergoing a significant transformation as artificial intelligence (AI) and machine learning (ML) infiltrate its traditionally hands-on processes. Time-consuming procedures involving controlled environments, manual
CAR-T cell therapies have revolutionized cancer treatment by leveraging patients' own immune cells to combat the disease. Since their introduction in 2017, over 30,000 patients have benefited from these treatments, and with an estimated two million more patients expected to be eligible in the
Since its inception in 2004, Sentry BioPharma Services Inc. has played a pivotal role in the life science industry by providing essential cold chain storage and distribution services. Sentry BioPharma is on a mission to maintain the integrity of highly temperature-sensitive pharmaceuticals,
The biopharma industry is on the brink of significant transformation as it moves toward 2025, driven by advancements in drug development, manufacturing technologies, and an increased focus on sustainability and supply chain resilience. With ongoing innovation, the industry is poised to address
